1-9 of 9
Authors: Chenlin Hu
Journal Article
435. Evaluation of Fecal Pharmacokinetics and Metagenomic Changes Following the Administration of Intravenous Omadacycline to Healthy Subjects Open Access
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.149, https://doi.org/10.1093/ofid/ofae631.149
Published: 29 January 2025
Journal Article
2063. Elucidating the Gram-Positive Selective Spectrum Activity of Ibezapolstat; Secondary Analysis from the phase 2a trial Open Access
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.133, https://doi.org/10.1093/ofid/ofad500.133
Published: 27 November 2023
Journal Article
277. A Functional OMICs Evaluation of Omadacycline to Understand Anti-Clostridioides difficile Protective Effects Open Access
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.349, https://doi.org/10.1093/ofid/ofad500.349
Published: 27 November 2023
Journal Article
521. Investigating the Gram-Positive Selective Spectrum of Ibezapolstat, a First-in-Class DNA Polymerase IIIC (Pol IIIC) Inhibitor Open Access
Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, December 2022, ofac492.576, https://doi.org/10.1093/ofid/ofac492.576
Published: 15 December 2022
Journal Article
489. Bile Acid Concentrations in Healthy Volunteers Receiving Oral Omadacycline or Vancomycin Open Access
Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, December 2022, ofac492.547, https://doi.org/10.1093/ofid/ofac492.547
Published: 15 December 2022
Journal Article
701. An Open-label Phase 2a Study of Ibezapolstat, a Unique Gram-positive Selective Spectrum (GPSS) Antibiotic, for Patients with Clostridioides difficile Infection Open Access
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Page S451, https://doi.org/10.1093/ofid/ofab466.898
Published: 04 December 2021
Journal Article
1052. Characterisation of the DNA binding properties of ridinilazole, a selective antibiotic currently in phase III trials for the treatment of Clostridioides difficile Open Access
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Page S617, https://doi.org/10.1093/ofid/ofab466.1246
Published: 04 December 2021
Journal Article
381. Morphologic Changes Associated With Echinocandin Tolerance Enhance Immunoevasion of Candida glabrata Open Access
Open Forum Infectious Diseases, Volume 5, Issue suppl_1, November 2018, Page S148, https://doi.org/10.1093/ofid/ofy210.392
Published: 26 November 2018
Journal Article
382. Virulence in Candida glabrata Is Not Attenuated by FKS Mutations but Associated With the Frequency of Cells With Distinct Morphology Open Access
Open Forum Infectious Diseases, Volume 5, Issue suppl_1, November 2018, Page S148, https://doi.org/10.1093/ofid/ofy210.393
Published: 26 November 2018
